Bruker Corporation

    Jurisdiction
    United States
    LEI
    LEBZ6VLQ6I8XB1NHVY15
    ISIN
    US1167941087 (BRKR)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    52 / 100
    Better than peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    €40.74 31.0% undervalued
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. Read full profile

    Fundamentals

    Net revenue
    €2.94B
    Gross margin
    48.0%
    EBIT
    €156.86M
    EBIT margin
    5.3%
    Net income
    €67.89M
    Net margin
    2.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.99B +1.7% €302.17M +345.1%
    €3.13B +4.9% €337.29M +11.6%
    €3.30B +5.2% €366.89M +8.8%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.05
    Ex date
    Payment date
    Dividend payout ratio
    38.2%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 284K $11.84M +218K Buy

    Earnings Calls

    Latest earnings call: May 2, 2024 (Q1 2024)

    Add to watchlist

    Notifications